Test Cover Image of:  Drug Metabolism and Personalized Therapy

Drug Metabolism and Personalized Therapy

Official journal of the European Society of Pharmacogenomics and Personalised Therapy

Editor In Chief: Adrián Llerena
Editorial Board: Mongi Benjeddou, Bing Chen, Jaroslav A. Hubacek, Magnus Ingelman-Sundberg, Vangelis G. Manolopoulos, Janja Marc, Urs A. Meyer, Sujit Nair, Charity Nofziger, Ana Peiro, Maurizio Simmaco, Ron van Schaik, Jae-Gook Shin and Sophie Visvikis-Siest
Your benefits:
  • Comprehensive approach to drug metabolism research
  • State-of-the-art research results
  • Renowned editorial board
  • High quality peer-review

Drug Metabolism and Personalized Therapy is the official journal of the European Society of Pharmacogenomics and Personalised Therapy (ESPT).

Objective
Drug Metabolism and Personalized Therapy (DMPT) is a peer-reviewed journal, and is abstracted/indexed in relevant major Abstracting Services. It provides up-to-date research articles, reviews and opinion papers in the wide field of drug metabolism research, covering established, new and potential drugs, environmentally toxic chemicals, the mechanisms by which drugs may interact with each other and with biological systems, and the pharmacological and toxicological consequences of these interactions and drug metabolism and excretion.

Topics
  • drug metabolizing enzymes
  • pharmacogenetics and pharmacogenomics
  • biochemical pharmacology
  • molecular pathology
  • clinical pharmacology
  • pharmacokinetics and drug-drug interactions
  • immunopharmacology
  • neuropsychopharmacology

Article formats
Research Articles, Reviews and Mini Reviews, Opinion Papers, Short Communications, letters to the Editor, Case Reports, Editorials

Journal Metrics

Cite Score
1.01
SCImago Journal Rank
0.277
Scource Normalized Impact per Paper
0.446

Old titles of this journal

Founded in 1981 until 2014: Drug Metabolism and Drug Interactions

From 2015 onwards: Drug Metabolism and Personalized Therapy

Other publications in the field

Abstracting & Indexing

Drug Metabolism and Personalized Therapy is covered by the following services:

  • Baidu Scholar
  • Biobase
  • Cabell's Whitelist
  • Case
  • Chemical Abstracts Service (CAS) - CAplus
  • Chemical Abstracts Service (CAS) - SciFinder
  • CNKI Scholar (China National Knowledge Infrastructure)
  • CNPIEC - cnpLINKer
  • Dimensions
  • EBSCO (relevant databases)
  • EBSCO Discovery Service
  • Embase
  • Genamics JournalSeek
  • Google Scholar
  • Japan Science and Technology Agency (JST)
  • J-Gate
  • JournalTOCs
  • KESLI-NDSL (Korean National Discovery for Science Leaders)
  • Medline
  • Meta
  • Microsoft Academic
  • MyScienceWork
  • Naver Academic
  • Naviga (Softweco)
  • Norwegian Register for Scientific Journals, Series and Publishers
  • Primo Central (ExLibris)
  • ProQuest (relevant databases)
  • Publons
  • PubMed
  • PubsHub
  • QOAM (Quality Open Access Market)
  • ReadCube
  • Reaxys
  • SCImago (SJR)
  • SCOPUS
  • Semantic Scholar
  • Sherpa/RoMEO
  • Summon (ProQuest)
  • TDNet
  • TEMA Technik und Management
  • Text Mining
  • Ulrich's Periodicals Directory/ulrichsweb
  • WanFang Data
  • Web of Science - Biological Abstracts
  • Web of Science - BIOSIS Previews
  • Web of Science - International Pharmaceutical Abstracts
  • Web of Science - Prous Science Integrity
  • WorldCat (OCLC)

Submission
You can easily submit your manuscript online. Simply go to http://mc.manuscriptcentral.com/dmpt and you will be guided through the whole submission and publishing process.

Your benefits of publishing with us
  • Rapid publication times
  • No submission fee
  • Free color illustrations
  • Professional sales and marketing support
  • Optional open access publication
  • Accepted papers will be published online first as DOI-citable, forward-linked articles for quickest possible visibility for the scientific community
  • Every article easily discoverable because of SEO and comprehensive abstracting and indexing services
  • Convenient citation tracking via e-mail alert
  • Secure archiving by De Gruyter and the independent archiving service Portico
  • Professional sales and marketing support
Submission process
  • Submission of your paper via our submission management tool following the Information for Authors (you will be guided through every step of the submission process)
  • Single-blind peer review process
  • A decision on your paper is aspired within 3-5 weeks
  • Accepted articles are published online ahead of print approx. 3–4 weeks after acceptance
Please note
  • Manuscripts must be written in clear and concise English
  • Before submitting your article please have a look at our Publication Ethics Statement and our copyright agreement
  • Once your article is accepted you have the option to publish it open access
  • Our repository policy repository policy allows you to distribute 30 PDF copies of your published article to colleagues (the PDF has to include the information that it is an author's copy). Please also feel free to distribute the link to the online abstract.
  • If you have any general questions please visit our FAQ page for authors.
  • For more detailed information contact the DMPT Editorial Office at DMPT.editorial@degruyter.com

Hybrid Open Access

For complete details on hybrid open access publishing at De Gruyter please see: https://www.degruyter.com/page/560

Effective 1st January 2016, authors from an institution affiliated with either the Association of Dutch Universities (VSNU), the Consortium of Swiss Academic Libraries or some UK libraries participating in the Jisc Collections SMP may publish primary research and review articles open access in any of De Gruyter's OnlineOpen journals at a discount of 90% of the APC price. For more information and to confirm whether your institution is eligible please see the following:

The Netherlands: https://www.degruyter.com/page/1461
The UK: https://www.degruyter.com/page/1462
Switzerland: https://www.degruyter.com/page/1463

Editor-in-Chief
Adrián LLerena
CICAB Clinical Research Center, Extremadura University Hospital, Badajoz, Spain
allerena@unex.es

Associate Editor
Vangelis G. Manolopoulos, Dept. of Pharmacology, Democritus University of Thrace Medical School, Alexandroupolis, Greece

Editorial Board
Mongi Benjeddou, Dept. of Biotechnology, University of the Western Cape, Cape Town, South Africa
Bing Chen, Shanghai, Dept. of Laboratory Medicine, Jiaotong University, Shanghai, P.R. China
Jaroslav Hubacek, Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine
Magnus Ingelman-Sundberg, Dept. of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden
Janja Marc, Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia
Urs A. Meyer, Dept. of Pharmacology, Biocenter of the University of Basel, Basel, Switzerland
Sujit Nair, Pharmaceutical Sciences, University of Mumbai, Mumbai, India
Charity Nofziger, Insitute of Pharmacology and Toxicology, Paracelsus Medical University, Salzburg, Austria
Ana Peiró, University General Hospital of Alicante, Alicante, Spain
Jae-Gook Shin, Pharmacogenomics Research Center, Inje University College of Medicine, Busan, South Korea
Maurizio Simmaco, Dept. of Neurosciences, Faculty of Medicine & Psychology, Sapienza University of Rome, Rome, Italy
Ron H.N. van Schaik, Dept. of Clinical Chemistry, Erasmus Medical Center, Rotterdam, The Netherlands
Sophie Visvikis-Siest, INSERM U525, University of Lorraine, Nancy, France

Editorial Office
Heike Jahnke, Journal Editor
Walter de Gruyter GmbH
Genthiner Str. 13, 10785 Berlin, Germany
Tel. +49-30-26005-220; Fax: +49-30-26005-184; E-mail: dmpt.editorial@degruyter.com

$149.00
Online

Search